The DPYS gene helps your body break down uracil and thymine, two natural parts of genetic material. If this gene does not work well, these substances can build up, which may lead to a rare condition called dihydropyrimidinase deficiency. Some people have no clear symptoms, while others may have developmental delay, seizures, low muscle tone, or digestive symptoms. Variants in the DPYS gene can also raise the chance of strong side effects from certain chemotherapy medicines, including 5-fluorouracil and capecitabine.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Others mainly help regulate when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to explore this topic in more detail, you can learn more in the LearnHub.
Overview
DPYSGene function
What if the gene works
Your cells use the DPYS gene to help break down uracil and thymine, two normal DNA building blocks. This supports the body’s usual recycling and waste removal of these substances.
Risk
What if the gene does not work
Variants in the DPYS gene can cause dihydropyrimidinase deficiency. Some people have no symptoms, while others develop seizures, developmental delay, intellectual disability, or digestive problems. Milder and more severe variants can influence which features appear and how early they start.
Treatment
What does that mean for your treatment
No DPYS-specific treatment or management approach is currently established. In research settings, loss-of-function variants in the DPYS gene are being studied as a possible marker of higher toxicity from fluoropyrimidine medicines such as 5-fluorouracil and capecitabine, but this is not part of standard treatment guidance.
Conditions associated with DPYS
Gene function
What if the gene works
As DNA and RNA are naturally broken down, your cells need a safe way to process the leftover parts. The DPYS gene helps clear certain building blocks from this routine turnover. Learning what the DPYS gene does in the body helps explain how cells manage everyday recycling and chemical balance.
The DPYS gene helps your body break down uracil and thymine, two natural parts of DNA and RNA. Its protein carries out a middle step in this cleanup pathway so these materials can be processed further.
By keeping this breakdown pathway moving, the DPYS gene supports the normal recycling and disposal of worn out genetic material. This helps cells maintain a steady balance of small molecules during everyday turnover.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. Variants are common and help shape normal human diversity, including differences in appearance, metabolism, and the body’s response to environmental influences. Many do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more strongly change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DPYS gene can change the shape or stability of dihydropyrimidinase, so cells produce an enzyme with reduced activity or none at all. This is how DPYS gene variants affect enzyme activity: milder variants may leave some function, while more severe variants can disrupt protein folding or create a shortened protein. That range often influences how much pyrimidine breakdown is impaired and, in dihydropyrimidinase deficiency, may affect when features appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the DPYS gene cause dihydropyrimidinuria, a rare inherited condition and the main disease clearly linked to DPYS gene variants. People with this condition may have developmental delay, seizures, a small head size, or stomach and bowel symptoms, while some remain mildly affected or have no obvious symptoms. A diagnosis is usually confirmed when both copies of the DPYS gene carry disease-causing variants.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence that specific lifestyle or environmental factors strongly change health risks linked to the DPYS gene. Personal risk is mainly shaped by whether someone has a harmful change in one or both copies of DPYS and by family history.
Inheritance of DPYS variants
DPYS-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops DPYS deficiency only when they inherit two disease-causing variants in the DPYS gene, one from each parent. Parents who each carry one variant are typically carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without either variant. In practical terms, DPYS gene inheritance often appears in families only when both parents silently carry the same condition-linked variant.
What does my DPYS result mean for my family?
For DPYS, family implications usually follow a recessive pattern, which means parents of an affected child are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other close relatives could be carriers as well. This can matter for family planning and for relatives who want to better understand their own chances of passing the variant on.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the DPYS gene, doctors use genetic testing with a blood or saliva sample. In simple terms, how DPYS genetic testing works is that a lab reads the DNA sequence of the DPYS gene and reports whether any clinically important variants are found.
When should I consider getting a genetic test?
Consider DPYS testing if there is a personal or family history of a rare inherited problem with breaking down pyrimidines, especially when it comes with seizures, developmental delay, or repeated stomach problems. It may also be discussed after an unusually severe reaction to fluorouracil or capecitabine chemotherapy.
A genetic result is only one part of your health story
A genetic result may be informative, but how much it can tell you depends on the condition and the type of variant. Over time, many factors influence how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information serves as context rather than certainty and is most useful when considered with other parts of care. In other situations, the result may offer a clear answer. In areas such as medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly or more quickly than another, which can change how strongly it works or how likely side effects are. These differences are common and help explain why the same treatment can feel very different from one person to the next.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes shape a person’s response to medications. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. More information about this topic is available in LearnHub.
Drugs influenced by the DPYS gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so general questions about side effects or treatment are best discussed with your doctor. DPYS has been studied in relation to fluorouracil-type cancer medicines because rare changes may affect how the body breaks them down, but this is not routine guidance.
History
DPYS came into medical view through reports of a rare inherited condition later linked to problems breaking down pyrimidines, which are normal building blocks of DNA and RNA. Early descriptions focused on unusual urine test findings and neurologic or developmental features in affected children rather than on the gene itself. From these first observations, research expanded steadily. As genetic testing improved in the late 1990s and early 2000s, researchers connected the condition to variants in the DPYS gene and confirmed dihydropyrimidinase deficiency as a distinct inherited condition. Later work helped clarify that some people are identified because of symptoms, while others are found through laboratory testing or family studies. This history shaped today’s understanding of DPYS as part of a small but well-defined group of genes involved in pyrimidine metabolism.